Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer

Clinical trial NCT00399035 · COMPLETED

Trial details

NCT number: NCT00399035
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2006-11-01
Primary completion: 2010-03-01
Enrollment: 1254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.